Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Reflections on therapeutic trials]

P Coumel1

  • 1Service de cardiologie, hôpital Lariboisière, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Empirical therapeutic trials risk overlooking drug mechanisms, hindering research. Reevaluating medical experimentation rules is crucial for advancing drug development and efficacy, especially in complex fields like sudden death prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[From provocation tests to clinical practice: invasive and non-invasive electrophysiology].

Archives des maladies du coeur et des vaisseaux·2003
Same author

[Indications for implantable automatic defibrillators: critical analysis].

Archives des maladies du coeur et des vaisseaux·2003
Same author

Safety of a controlled-release flecainide acetate formulation in the prevention of paroxysmal atrial fibrillation in outpatients.

Annales de cardiologie et d'angeiologie·2003
Same author

Atrial fibrillation: one more sporting inconvenience?

European heart journal·2002
Same author

Learning from mistakes: the case of clinical electrophysiology: a perspective on evidence-based rhythmology.

Circulation·2001
Same author

Sotalol: a fool's deal?

European heart journal·2001
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Medical Research

Context:

  • Current therapeutic trials often rely on empiricism, focusing on correlation over causation.
  • This empirical approach can lead to challenges when evaluation criteria lack expected correlational value.
  • Examples include antiarrhythmic drugs and beta-blockers in sudden death prevention, where efficacy was observed without fully understanding mechanisms.

Purpose:

  • To highlight the limitations of empirical research in drug efficacy evaluation.
  • To advocate for a shift towards understanding drug mechanisms of action.
  • To call for a reevaluation of medical experimentation protocols.

Summary:

  • Research that establishes cause-and-effect relationships contrasts with the empiricism common in therapeutic trials.

Related Experiment Videos

  • Ignoring drug mechanisms of action during efficacy evaluation poses risks, potentially halting research lines.
  • This approach has impeded progress in areas like sudden death prevention, necessitating a review of experimental rules.

    • Impact:

    • Revising medical experimentation rules can improve the feasibility and efficacy of drug development.
    • Understanding mechanisms of action is vital for overcoming research impasses.
    • This could foster innovation and the development of novel therapeutics in complex medical fields.